Acurx Pharma Discontinues Phase 2b Trial For Ibezapolstat To Treat C. Difficile Infection

RTTNews | 672 dagar sedan
Acurx Pharma Discontinues Phase 2b Trial For Ibezapolstat To Treat C. Difficile Infection

(RTTNews) - Biopharmaceutical company Acurx Pharmaceuticals, Inc. (ACXP) announced Monday that the Company has discontinued the Phase 2b clinical trial of its lead antibiotic candidate, ibezapolstat, for the treatment of patients with Clostridioides difficile infection (CDI) due to success.

The Company made this decision in consultation with its medical and scientific advisors and statisticians based on observed aggregate blinded data and other factors, including the cost to maintain clinical trial sites and slow enrollment due to COVID-19.

The Company has determined that the trial performed as anticipated for both treatments, ibezapolstat and the control antibiotic vancomycin (a standard of care to treat patients with CDI), with high rates of clinical cure observed across the trial without any emerging safety concerns.

Accordingly, the Independent Data Monitoring Committee will not be required to perform an interim analysis of this Phase 2b trial data as originally planned and the Company has discontinued the trial.

Acurx will analyze the data and report topline efficacy results promptly. The Company anticipates that this decision will allow the Company to advance this first-in-class, FDA QIDP/Fast Track-designated antibiotic product candidate to Phase 3 clinical trials more expeditiously.

read more
BoJ Minutes: Japan Economy Continues To Recover

BoJ Minutes: Japan Economy Continues To Recover

Members of the Bank of Japan's Monetary Policy Board felt that the country's economic recovery is continuing at an acceptable pace, minutes from the central bank's June 16-17 monetary policy meeting revealed on Tuesday - although it is starting to show signs of slowing.
RTTNews | 4 minuter sedan
Singapore Shares Poised To Open To The Upside On Tuesday

Singapore Shares Poised To Open To The Upside On Tuesday

The Singapore stock market on Monday halted the six-day losing streak in which it had stumbled almost 120 points or 2.9 percent. The Straits Times Index now sits just beneath the 4,200-point plateau and it may extend its gains on Tuesday.
RTTNews | 6 minuter sedan
Renewed Support Likely For Malaysia Stock Market

Renewed Support Likely For Malaysia Stock Market

The Malaysia stock market has alternated between positive and negative finishes through the last four trading days since the end of the three-day losing streak in which it had fallen more than 15 points or 1 percent. The Kuala Lumpur Composite Index now sits just above the 1,525-point plateau although it's likely to bounce higher again on Tuesday.
RTTNews | 36 minuter sedan
Japan Stock Market May Stop The Bleeding On Tuesday

Japan Stock Market May Stop The Bleeding On Tuesday

The Japan stock market has moved lower in two straight sessions, tumbling almost 780 points or 1.8 percent along the way. The Nikkei 225 now sits just shy of the 40,300-point plateau although it's due for support on Tuesday.
RTTNews | 51 minuter sedan
South Korea Inflation Rises 0.2% In July

South Korea Inflation Rises 0.2% In July

Overall consumer prices in South Korea were up a seasonally adjusted 0.2 percent on month in July, Statistics Korea said on Tuesday.
RTTNews | 56 minuter sedan
Australia Services Sector Accelerates In July

Australia Services Sector Accelerates In July

The services sector in Australia continued to expand in July, and at a faster pace, the latest survey from S&P Global revealed on Tuesday with a services PMI score of 54.1.
RTTNews | 1h 2minuter sedan